Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - AEOLUS PHARMACEUTICALS, INC. | v228137_8k.htm |
Exhibit 16.1
July 7, 2011
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, N.E.
Washington, DC 20549-7561
Dear Sir or Madam:
We have been furnished with a copy of and read the disclosure contained in Item 4.01, “Changes in Registrant’s Certifying Accountant,” of Aeolus Pharmaceuticals, Inc.’s Current Report on Form 8-K dated July 6, 2011. We agree with the statements concerning our firm contained therein.
Very truly yours,
/s/ Haskell & White LLP